ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BMY Bristol Myers Squibb Co

44.88
0.18 (0.40%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bristol Myers Squibb Co NYSE:BMY NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.18 0.40% 44.88 45.37 44.34 44.73 21,281,928 01:00:00

Statement of Changes in Beneficial Ownership (4)

03/03/2021 10:28pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Elkins David V
2. Issuer Name and Ticker or Trading Symbol

BRISTOL MYERS SQUIBB CO [ BMY ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP, Chief Financial Officer
(Last)          (First)          (Middle)

430 E. 29TH STREET, 14TH FLOOR
3. Date of Earliest Transaction (MM/DD/YYYY)

3/1/2021
(Street)

NEW YORK, NY 10016
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.10 par value 3/1/2021  M  24579 (1)A$0 91759 D  
Common Stock, $0.10 par value 3/1/2021  F  8573 (2)D$61.63 83186 D  
Common Stock, $0.10 par value         195 (3)I 401K 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units  (4)3/1/2021  M   24579 (1)    (1)3/1/2022 (1)Common Stock, $0.10 par value 24579.0 $0 24577 D  

Explanation of Responses:
(1) Each restricted stock unit vests in three equal installments beginning on March 1, 2020.
(2) Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
(3) Based on recent 401(k) plan statement.
(4) Each restricted stock unit converts into one share of common stock upon vesting.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Elkins David V
430 E. 29TH STREET
14TH FLOOR
NEW YORK, NY 10016


EVP, Chief Financial Officer

Signatures
/s/ Lisa A. Atkins, attorney-in-fact for David V. Elkins3/3/2021
**Signature of Reporting PersonDate

1 Year Bristol Myers Squibb Chart

1 Year Bristol Myers Squibb Chart

1 Month Bristol Myers Squibb Chart

1 Month Bristol Myers Squibb Chart

Your Recent History

Delayed Upgrade Clock